ژیامین، چین، 13 ستمبر 2024ء/سنہوا-ایشیانیٹ/– ایک غیر ملکی کمپنی لائف ٹائم (زیامین) پلاسٹک پروڈکٹس کمپنی لمیٹڈ (”لائف ٹائم”) نے حال ہی میں ہائی کانگ ڈسٹرکٹ، ژیامین میں ہائی ٹیک مواد سے تیار کردہ 6.5 ملین ملٹی فنکشنل تفریحی مصنوعات کے ذریعہ اپنی سالانہ صلاحیت میں اضافہ کرنے کا اعلان کیا ہے، یہ فیصلہ اس کے […]
Deriv Honoured with ‘Best Customer Service’ Award at Global Forex Awards
Deriv’s client-first philosophy earns the ‘Best Customer Service’ award at the Global Forex Awards, coinciding with its 25th year of empowering traders. 2024 is the year of wins for Deriv, which earlier this year won the ‘Most Trusted Broker’, ‘Best Trading Experience’ (LATAM) 2024, and ‘Best Latam Region Broker’ awards. Deriv receives Best Customer Service […]
AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies
AI-Media and Speechmatics Partnership BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. […]
AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies
AI-Media and Speechmatics Partnership BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. […]
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]